학술논문
725MO Phase I trial of the DLL3/CD3 IgG-like T cell engager BI 764532 in patients (pts) with DLL3-positive (+) tumours: Focus on neuroendocrine carcinomas
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S499-S500
Subject
Language
ISSN
0923-7534